Cargando…
Optic neuropathy associated with the use of over-the-counter sexual enhancement supplements
This case report details an association of the use of over-the-counter sexual enhancement supplements with atypical optic neuropathy. A 42-year-old man presented with right-sided headache and vision loss of the right eye, which deteriorated to a single quadrant of hand motion over 11 days. Serial or...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4218916/ https://www.ncbi.nlm.nih.gov/pubmed/25378904 http://dx.doi.org/10.2147/OPTH.S73059 |
_version_ | 1782342496625360896 |
---|---|
author | Karli, Sapir Z Liao, Sophie D Carey, Andrew R Lam, Byron L Wester, Sara T |
author_facet | Karli, Sapir Z Liao, Sophie D Carey, Andrew R Lam, Byron L Wester, Sara T |
author_sort | Karli, Sapir Z |
collection | PubMed |
description | This case report details an association of the use of over-the-counter sexual enhancement supplements with atypical optic neuropathy. A 42-year-old man presented with right-sided headache and vision loss of the right eye, which deteriorated to a single quadrant of hand motion over 11 days. Serial orbital magnetic resonance imaging scans demonstrated progressive orbital optic nerve enhancement extending into the optic canal despite high-dose steroid treatment. The patient eventually admitted to using several over-the-counter sexual enhancement supplements prior to the onset of symptoms and throughout the course of his steroid treatment, which he subsequently discontinued. His vision improved to 20/200 with an expanded visual field. Anterior ischemic optic neuropathy has been reported in association with phosphodiesterase (PDE)-5 inhibitor use, but visual loss in association with unregulated sexual enhancement supplements has not been studied. While one case cannot establish association, our case is suggestive of potential dangers of over-the-counter sexual enhancement supplements, which may contain PDE-5 inhibitors, “male hormones,” and “substances that enhance blood production.” The case also underscores the importance of obtaining a careful history of supplements in patients with optic neuropathies. |
format | Online Article Text |
id | pubmed-4218916 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-42189162014-11-06 Optic neuropathy associated with the use of over-the-counter sexual enhancement supplements Karli, Sapir Z Liao, Sophie D Carey, Andrew R Lam, Byron L Wester, Sara T Clin Ophthalmol Case Report This case report details an association of the use of over-the-counter sexual enhancement supplements with atypical optic neuropathy. A 42-year-old man presented with right-sided headache and vision loss of the right eye, which deteriorated to a single quadrant of hand motion over 11 days. Serial orbital magnetic resonance imaging scans demonstrated progressive orbital optic nerve enhancement extending into the optic canal despite high-dose steroid treatment. The patient eventually admitted to using several over-the-counter sexual enhancement supplements prior to the onset of symptoms and throughout the course of his steroid treatment, which he subsequently discontinued. His vision improved to 20/200 with an expanded visual field. Anterior ischemic optic neuropathy has been reported in association with phosphodiesterase (PDE)-5 inhibitor use, but visual loss in association with unregulated sexual enhancement supplements has not been studied. While one case cannot establish association, our case is suggestive of potential dangers of over-the-counter sexual enhancement supplements, which may contain PDE-5 inhibitors, “male hormones,” and “substances that enhance blood production.” The case also underscores the importance of obtaining a careful history of supplements in patients with optic neuropathies. Dove Medical Press 2014-10-29 /pmc/articles/PMC4218916/ /pubmed/25378904 http://dx.doi.org/10.2147/OPTH.S73059 Text en © 2014 Karli et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Case Report Karli, Sapir Z Liao, Sophie D Carey, Andrew R Lam, Byron L Wester, Sara T Optic neuropathy associated with the use of over-the-counter sexual enhancement supplements |
title | Optic neuropathy associated with the use of over-the-counter sexual enhancement supplements |
title_full | Optic neuropathy associated with the use of over-the-counter sexual enhancement supplements |
title_fullStr | Optic neuropathy associated with the use of over-the-counter sexual enhancement supplements |
title_full_unstemmed | Optic neuropathy associated with the use of over-the-counter sexual enhancement supplements |
title_short | Optic neuropathy associated with the use of over-the-counter sexual enhancement supplements |
title_sort | optic neuropathy associated with the use of over-the-counter sexual enhancement supplements |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4218916/ https://www.ncbi.nlm.nih.gov/pubmed/25378904 http://dx.doi.org/10.2147/OPTH.S73059 |
work_keys_str_mv | AT karlisapirz opticneuropathyassociatedwiththeuseofoverthecountersexualenhancementsupplements AT liaosophied opticneuropathyassociatedwiththeuseofoverthecountersexualenhancementsupplements AT careyandrewr opticneuropathyassociatedwiththeuseofoverthecountersexualenhancementsupplements AT lambyronl opticneuropathyassociatedwiththeuseofoverthecountersexualenhancementsupplements AT westersarat opticneuropathyassociatedwiththeuseofoverthecountersexualenhancementsupplements |